Literature DB >> 25789218

Synthesis and in vitro evaluation of amphiphilic peptides and their nanostructured conjugates.

Samaneh Mohammadi1, Javid Shahbazi Mojarrad2, Parvin Zakeri-Milani3, Ali Shirani1, Samad Mussa Farkhani1, Naser Samadi1, Hadi Valizadeh4.   

Abstract

PURPOSE: Breast cancer is the second leading cancer type among people of advanced countries. Various methods have been used for cancer treatment such as chemotherapy and radiotherapy. In the present study we have designed and synthesized a new group of drug delivery systems (DDS) containing a new class of Cell Penetrating Peptides (CPPs) named Peptide Amphiphiles (PAs).
METHODS: Two PAs and anionic peptides were synthesized using solid phase peptide synthesis (SPPS), namely [KW]4, [KW]5, E4 and E8. Then nano-peptides were synthesized by non-covalent binding between PAs and poly anions as [KW]4-E4, [KW]4-E8, [KW]5-E4 and [KW]5-E8.
RESULTS: Flow cytometry studies showed that increased chain length of PAs with a higher ratio between hydrophobicity and net charge results in increased intracellular uptake by MCF7 cells after 2h incubation. Moreover, nano-peptides showed greater intracellular uptake compared to PAs. Anti-proliferative assay revealed that by increasing chain length of PAs, the toxicity effect on MCF7 cells is reduced, however nano-peptides did not show significant toxicity on MCF7 cells even at high concentration levels.
CONCLUSION: These data suggest that due to the lack of toxicity effect at high concentration levels and also high cellular uptake, nano-peptides are more suitable carrier compared to PAs for drug delivery.

Entities:  

Keywords:  Amphiphilic Peptides; Cell Penetrating Peptides; Cellular Uptake; Drug Delivery System; Fluorescein Isothiocyanate; Solid Phase Peptide Synthesis

Year:  2015        PMID: 25789218      PMCID: PMC4352222          DOI: 10.5681/apb.2015.006

Source DB:  PubMed          Journal:  Adv Pharm Bull        ISSN: 2228-5881


  30 in total

1.  The pharmacokinetics of cell-penetrating peptides.

Authors:  Dikran Sarko; Barbro Beijer; Regine Garcia Boy; Eva-Maria Nothelfer; Karin Leotta; Michael Eisenhut; Annette Altmann; Uwe Haberkorn; Walter Mier
Journal:  Mol Pharm       Date:  2010-10-07       Impact factor: 4.939

Review 2.  Cell penetrating elastin-like polypeptides for therapeutic peptide delivery.

Authors:  Gene L Bidwell; Drazen Raucher
Journal:  Adv Drug Deliv Rev       Date:  2010-05-15       Impact factor: 15.470

3.  Rationale-based, de novo design of dehydrophenylalanine-containing antibiotic peptides and systematic modification in sequence for enhanced potency.

Authors:  Sarika Pathak; Virander Singh Chauhan
Journal:  Antimicrob Agents Chemother       Date:  2011-02-14       Impact factor: 5.191

Review 4.  Critical parameters in drug delivery by intravenous infusion.

Authors:  Robert A Peterfreund; James H Philip
Journal:  Expert Opin Drug Deliv       Date:  2013-04-09       Impact factor: 6.648

5.  Slow release and delivery of antisense oligonucleotide drug by self-assembled peptide amphiphile nanofibers.

Authors:  Selma Bulut; Turan S Erkal; Sila Toksoz; Ayse B Tekinay; Turgay Tekinay; Mustafa O Guler
Journal:  Biomacromolecules       Date:  2011-07-07       Impact factor: 6.988

6.  The third helix of the Antennapedia homeodomain translocates through biological membranes.

Authors:  D Derossi; A H Joliot; G Chassaing; A Prochiantz
Journal:  J Biol Chem       Date:  1994-04-08       Impact factor: 5.157

Review 7.  Friends or foes - bipolar effects of the tumour stroma in cancer.

Authors:  Margareta M Mueller; Norbert E Fusenig
Journal:  Nat Rev Cancer       Date:  2004-11       Impact factor: 60.716

8.  Efficient delivery of cell impermeable phosphopeptides by a cyclic peptide amphiphile containing tryptophan and arginine.

Authors:  Amir Nasrolahi Shirazi; Rakesh Kumar Tiwari; Donghoon Oh; Antara Banerjee; Arpita Yadav; Keykavous Parang
Journal:  Mol Pharm       Date:  2013-04-15       Impact factor: 4.939

9.  Self-assembling peptide amphiphile-based nanofiber gel for bioresponsive cisplatin delivery.

Authors:  Jin-Ki Kim; Joel Anderson; Ho-Wook Jun; Michael A Repka; Seongbong Jo
Journal:  Mol Pharm       Date:  2009 May-Jun       Impact factor: 4.939

10.  Enhancing cellular uptake of activable cell-penetrating peptide-doxorubicin conjugate by enzymatic cleavage.

Authors:  Nian-Qiu Shi; Wei Gao; Bai Xiang; Xian-Rong Qi
Journal:  Int J Nanomedicine       Date:  2012-03-26
View more
  4 in total

1.  Cellular uptake and anti-tumor activity of gemcitabine conjugated with new amphiphilic cell penetrating peptides.

Authors:  Parvin Zakeri-Milani; Samad Mussa Farkhani; Ali Shirani; Samaneh Mohammadi; Javid Shahbazi Mojarrad; Jafar Akbari; Hadi Valizadeh
Journal:  EXCLI J       Date:  2017-05-09       Impact factor: 4.068

2.  Effects of self-assembled cell-penetrating peptides and their nano-complexes on ABCB1 expression and activity.

Authors:  Mehri Niazi; Parvin Zakeri-Milani; Mehdi Soleymani-Goloujeh; Ali Mohammadi; Muhammad Sarfraz; Raimar Löbenberg; Saeedeh Najafi-Hajivar; Javid Shahbazi-Mojarrad; Masoud Farshbaf; Hadi Valizadeh
Journal:  Iran J Basic Med Sci       Date:  2021-03       Impact factor: 2.699

3.  Cytotoxicity and Immunogenicity Evaluation of Synthetic Cell-penetrating Peptides for Methotrexate Delivery.

Authors:  Parvin Zakeri-Milani; Saeedeh Najafi-Hajivar; Muhammad Sarfraz; Ali Nokhodchi; Hamed Mohammadi; Soheila Montazersaheb; Mehri Niazi; Maryam Hemmatzadeh; Mehdi Soleymani-Goloujeh; Behzad Baradaran; Javid Shahbazi Mojarrad; Masoud Farshbaf; Tooba Gholikhani; Hadi Valizadeh
Journal:  Iran J Pharm Res       Date:  2021       Impact factor: 1.696

4.  An Amphiphilic Peptide Induces Apoptosis Through the miR29b-p53 Pathway in Cancer Cells.

Authors:  Soyoung Kim; Jung Hyun Lee; Igojo Kang; Soonsil Hyun; Jaehoon Yu; Chanseok Shin
Journal:  Mol Ther Nucleic Acids       Date:  2016-07-05       Impact factor: 10.183

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.